Cilostazol

Product NDC: 0054-0044
11-digit product format: 000540044
Labeler code: 0054
Product ID: 0054-0044_d872300b-ff60-4709-a667-aab53462bfac
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cilostazol
Dosage form: TABLET
Route: ORAL
Labeler: West-Ward Pharmaceuticals Corp.
Application: ANDA077024
Marketing category: ANDA
Marketing start: 2005-05-17
Marketing end: 0000-00-00
Substance: CILOSTAZOL
Active strength: 100 mg/1
Pharmacologic classes: Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0054-0044		D	Discontinued by firm	2026-08-07
excluded package	package	0054-0044	0054-0044-21	D	Discontinued by firm	2026-08-07
excluded package	package	0054-0044	0054-0044-29	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0054-0044-29	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0054-0044-21	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0054-0044-29	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0054-0044-21	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0054-0044-29	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0054-0044-21	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0054-0044-29	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0054-0044-21	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0054-0044-29	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0054-0044-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0054-0044-29	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0054-0044-21	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0054-0044-29	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0054-0044-21	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0054-0044-29	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0054-0044-21	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0054-0044-29	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0054-0044-21	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0054-0044-29	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0054-0044-21	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0054-0044-29	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0054-0044-21	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0054-0044-29	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0054-0044-21	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077024-001	CILOSTAZOL	CILOSTAZOL	50MG	TABLET / ORAL			2005-05-17
A077024-002	CILOSTAZOL	CILOSTAZOL	100MG	TABLET / ORAL			2005-05-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077024-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077024-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077024-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077024-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077024-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077024-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077024-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077024-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077024-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077024-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077024-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077024-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077024-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A077024-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077024-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A077024-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077024-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A077024-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077024-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077024-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077024-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077024-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077024-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077024-002	AB	1	`ea99ee380514…`
2022-10-28 04:53 UTC	2022-10	A077024-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A077024-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A077024-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A077024-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077024-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077024-002	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c114def4-591e-cde9-1a9f-29af28d4c1ea	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
0054-0044-21	2022-08-05	These highlights do not include all the information needed to use CILOSTAZOL TABLETS safely and effectively. See full prescribing information for CILOSTAZOL TABLETS. CILOSTAZOL tablets, for oral use Initial U.S. Approval: 1999
0054-0044-29	2022-08-05	These highlights do not include all the information needed to use CILOSTAZOL TABLETS safely and effectively. See full prescribing information for CILOSTAZOL TABLETS. CILOSTAZOL tablets, for oral use Initial U.S. Approval: 1999
0054-0044-21	2022-07-29	These highlights do not include all the information needed to use CILOSTAZOL TABLETS safely and effectively. See full prescribing information for CILOSTAZOL TABLETS. CILOSTAZOL tablets, for oral use Initial U.S. Approval: 1999
0054-0044-29	2022-07-29	These highlights do not include all the information needed to use CILOSTAZOL TABLETS safely and effectively. See full prescribing information for CILOSTAZOL TABLETS. CILOSTAZOL tablets, for oral use Initial U.S. Approval: 1999

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0054-0044-21	EA - Each	0054-0044	07a314f3-f5a7-4730-b33b-574f4b31581c	1	2012-07-24
0054-0044-29	EA - Each	0054-0044	7c21aeb0-3e8b-49ec-b8bc-ccfd2cc3239c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CILOSTAZOL	ACTIVE INGREDIENT	N7Z035406B	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
CILOSTAZOL	ACTIVE MOIETY	N7Z035406B	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CILOSTAZOL TABLET [ROXANE LABORATORIES, INC]	12
CILOSTAZOL	ACTIVE INGREDIENT	N7Z035406B	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
CILOSTAZOL	ACTIVE MOIETY	N7Z035406B	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N7Z035406B	CILOSTAZOL	73963-72-1	CILOSTAZOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
242461	cilostazol 100 MG Oral Tablet	PSN	50fc64ac-7eb3-4bab-8de2-83cd5404d169	3
242461	cilostazol 100 MG Oral Tablet	SCD	50fc64ac-7eb3-4bab-8de2-83cd5404d169	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0054-0044-21	00054004421	60 TABLET in 1 BOTTLE (0054-0044-21)	60 tablet	2005-05-17	0000-00-00	No	No	Current
0054-0044-29	00054004429	500 TABLET in 1 BOTTLE (0054-0044-29)	500 tablet	2005-05-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cilostazol	West-Ward Pharmaceuticals Corp. \| West-Ward Columbus Inc.	2022-08-05	HUMAN PRESCRIPTION DRUG LABEL	15
Cilostazol	Carilion Materials Management	2016-08-06	HUMAN PRESCRIPTION DRUG LABEL	3